NCT07467772
- Conditions
- Adenosarcoma of the uterus, ESS, Endometrial Neoplasms, +25 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Endometrial Stromal Tumors
Explore clinical trials studying Endometrial Stromal Tumors. Study availability and eligibility vary by location and protocol.
20 public trials
2 recruiting studies
Endometrial Stromal Tumors trial results
NCT06277154
- Conditions
- Angiosarcoma, Desmoplastic Small Round Cell Tumor, Endometrial Neoplasms, +43 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, China
NCT04811196
- Conditions
- Endometrial Neoplasms, Endometrial Stromal Sarcoma, Endometrial Stromal Tumors, +31 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
Completed
FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study
NCT03926936
- Conditions
- Adenosarcoma of Uterus, Adenosarcoma of the uterus, Endometrial Cancer, +24 more
- Locations
-
- CHU de Liege Grivegnée, Liège, Belgium
- UZ Antwerp Edegem, Belgium
- UZ Gent Ghent, Belgium
- AZ Sint Maarten Mechelen, Belgium
NCT00053794
- Conditions
- Endometrial Cancer, Endometrial Neoplasms, Endometrial Stromal Tumors, +41 more
- Locations
-
- Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
- British Columbia Cancer Agency - Vancouver Island Cancer Centre Vancouver, British Columbia, Canada
- Margaret and Charles Juravinski Cancer Centre Hamilton, Ontario, Canada
- Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada
Completed
AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma
NCT00659360
- Conditions
- Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma, +41 more
- Locations
-
- Fox Chase Cancer Center Rockledge, Pennsylvania, United States
- Cross Cancer Institute Edmonton, Alberta, Canada
- University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada
- Montreal General Hospital Montreal, Quebec, Canada
NCT01210222
- Conditions
- Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, +21 more
- Locations
-
- Hartford Hospital Hartford, Connecticut, United States
- The Hospital of Central Connecticut New Britain, Connecticut, United States
- Sarasota Memorial Hospital Sarasota, Florida, United States
- Memorial University Medical Center Savannah, Georgia, United States
NCT02150213
- Conditions
- Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, Adrenal Gland Diseases, +23 more
- Locations
-
- Novartis Investigative Site Tallahassee, Florida, United States
- Novartis Investigative Site Baltimore, Maryland, United States
- Novartis Investigative Site Hoffman, New Jersey, United States
- Novartis Investigative Site Dallas, Texas, United States
Completed
Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
NCT00154388
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +121 more
- Locations
-
Not specified
NCT00897442
- Conditions
- Adenoma, Adnexal Diseases, Borderline Ovarian Clear Cell Tumor, +143 more
- Locations
-
- Highlands Oncology Group PA - Fayetteville Fayetteville, Arkansas, United States
- Washington Regional Medical Center - Fayetteville Fayetteville, Arkansas, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States